Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kim, Seung U  [Clear All Filters]
2014
Choi, S.S., Lee, S.-R., Kim, S.U., and Lee, H.J. (2014). Alzheimer's Disease and Stem Cell Therapy.Exp Neurobiol23, 45-52.
Kaneko, Y., Tajiri, N., Staples, M., Reyes, S., Lozano, D., Sanberg, P.R., Freeman, T.B., van Loveren, H., Kim, S.U., and Borlongan, C.V. (2014). Bone Marrow-Derived Stem Cell Therapy for Metastatic Brain Cancers.Cell Transplant.
Mooney, R., Weng, Y., Garcia, E., Bhojane, S., Smith-Powel, L., Kim, S.U., Annala, A.J., Aboody, K.S., and Berlin, J.M. (2014). Conjugation of pH-Responsive Nanoparticles to Neural Stem Cells Improves Intratumoral Therapy.J Control Release.
Lee, H.Jun, An, J., Doo, S.Whan, Kim, J.Heon, Choi, S.Sik, Lee, S.-R., Park, S.Won, Song, Y.Seob, and Kim, S.U. (2014). Improvement in Spinal Cord Injury-induced Bladder Fibrosis Using Mesenchymal Stem Cell Transplantation into the Bladder Wall.Cell Transplant.
Hwang, D.Won, Park, K.Min, Shim, H.-K., Jin, Y., Oh, H.Jeong, Oh, S.Won, Lee, S., Youn, H., Joung, Y.Ki, Lee, H.J., et al. (2014). In vivo bioluminescence imaging for viable human neural stem cells incorporated within in situ gelatin hydrogels.Ejnmmi Res4, 61.
Mooney, R., Roma, L., Zhao, D., Van Haute, D., Garcia, E., Kim, S.U., Annala, A.J., Aboody, K.S., and Berlin, J.M. (2014). Neural Stem Cell-Mediated Delivery of Gold Nanorods Improves Intratumoral Photothermal Therapy.Acs Nano.
Kim, W.Kyung, Kim, D., Cui, J., Jang, H.Hee, Kim, K.Sei, Lee, H.Jun, Kim, S.U., and Ahn, S.-M. (2014). Secretome analysis of human oligodendrocytes derived from neural stem cells.Plos One9, e84292.
2013
Kang, W., Seol, H.Jun, Seong, D.-H., Kim, J., Kim, Y., Kim, S.U., Nam, D.-H., and Joo, K.Min (2013). Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.Oncol Rep.
Natsume, A., Ito, M., Katsushima, K., Ohka, F., Hatanaka, A., Shinjo, K., Sato, S., Takahashi, S., Ishikawa, Y., Takeuchi, I., et al. (2013). Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.Cancer Res.
Yi, B.-R., Kim, S.U., and Choi, K.-C. (2013). Development and application of neural stem cells for treating various human neurological diseases in animal models.Lab Anim Res29, 131-137.
Tajiri, N., Dailey, T., Metcalf, C., Mosley, Y.I., Lau, T., Staples, M., van Loveren, H., Kim, S.U., Yamashima, T., Yasuhara, T., et al. (2013). In vivo animal stroke models: a rationale for rodent and non-human primate models.Transl Stroke Res4, 308-321.
Gutova, M., Frank, J.A., D'Apuzzo, M., Khankaldyyan, V., Gilchrist, M.M., Annala, A.J., Metz, M.Z., Abramyants, Y., Herrmann, K.A., Ghoda, L.Y., et al. (2013). Magnetic Resonance Imaging Tracking of Ferumoxytol-Labeled Human Neural Stem Cells: Studies Leading to Clinical Use.Stem Cells Transl Med.
Kwon, S.Keun, Kim, S.U., Song, J.-J., Cho, C.Gun, and Park, S.-W. (2013). Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells.Clin Exp Otorhinolaryngol6, 176-83.
Ishikawa, H., Tajiri, N., Shinozuka, K., Vasconcellos, J., Kaneko, Y., Lee, H.J., Mimura, O., Dezawa, M., Kim, S.U., and Borlongan, C.V. (2013). Vasculogenesis in Experimental Stroke After Human Cerebral Endothelial Cell Transplantation.Stroke.